FDA Drug Shortage Database
Riluzole (Rilutek) shortage
The FDA Drug Shortage Database lists 1 of 4 riluzole presentations as limited or unavailable (updated October 1, 2026); the first entry was posted on January 26, 2024. 3 more presentations are on the list as available.
- Generic listed
- In shortage
Check it at the source: the FDA Drug Shortage Database.
Which strengths are short?
| Strength | Limited or unavailable now | Listed now, available | Resolved or discontinued |
|---|---|---|---|
| 5mg/1ml suspension | 0 | 3 | 0 |
| 50mg/10ml suspension | 1 | 0 | 0 |
Which presentations are listed?
Limited or unavailable now (1)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Tiglutik, Oral Suspension, 50 mg/10 mL (NDC 70726-0303-1) | EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) | Current posted January 26, 2024, updated October 1, 2026 | Unavailable; Requirements related to complying with good manufacturing practices |
Listed now, available (3)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0304-1) | EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) | Current posted January 26, 2024, updated October 1, 2026 | Available |
| Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0305-1) | EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) | Current posted January 26, 2024, updated October 1, 2026 | Available |
| Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0306-1) | EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) | Current posted January 26, 2024, updated October 1, 2026 | Available |
Source: FDA Drug Shortage Database via openFDA, read October 8, 2026
What next?
- Every shortage now
- medicines by presentations in shortage